Stocksigma LogoStocksigma Logo

Tavexia Lifecare Board Approves Auditor Transition and Acquisition of Meyonex Pharmaceuticals

Tavexia Lifecare's board approved the resignation of statutory auditor M/s SSRV & Associates and appointed M/s DEVAM & Associates LLP for a five-year term

Tavexia Lifecare Board Approves Auditor Transition and Acquisition of Meyonex Pharmaceuticals

Sattva Sukun Lifecare Ltd 路 Change in Auditor 路 08 Sept 2026, 12:54 am

Tavexia Lifecare Board Approves Auditor Transition and Acquisition of Meyonex Pharmaceuticals Tavexia Lifecare's board approved the resignation of statutory auditor M/s SSRV & Associates and appointed M/s DEVAM & Associates LLP for a five-year term starting FY27, subject to shareholder approval at the 46th AGM. The board also authorized preliminary due diligence and negotiations to acquire up to a 60% equity stake in unlisted Meyonex Pharmaceuticals Ltd, which has a paid-up capital of Rs 13.998 cr. Additionally, the re-appointment of Khushboo Vasudev as Independent Director for a second five-year term was approved.

Original exchange filing (PDF)

More announcements from Sattva Sukun Lifecare Ltd

All Sattva Sukun Lifecare Ltd announcements